STOCK TITAN

[Form 4] NEXGEL, INC. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

NEXGEL, Inc. (NXGL) director Robert Henry Scott reported open-market sales under a Rule 10b5-1 plan. The earliest transaction date is 10/02/2025. He sold 825 shares on 10/02/2025 at $2.50 per share and 7,175 shares on 10/03/2025 at a weighted average price of $2.5502, reducing his direct holdings from 120,531 to 113,356 shares. The filing states the shares were originally purchased in the open market on 03/01/2024.

NEXGEL, Inc. (NXGL) direttore Robert Henry Scott ha riferito vendite sul mercato aperto nell'ambito di un piano Rule 10b5-1. La data di transazione più antica è 10/02/2025. Ha venduto 825 azioni il 10/02/2025 a $2.50 per azione e 7,175 azioni il 10/03/2025 a un prezzo medio ponderato di $2.5502, riducendo le sue partecipazioni dirette da 120,531 a 113,356 azioni. La dichiarazione indica che le azioni sono state originariamente acquistate sul mercato aperto il 03/01/2024.

NEXGEL, Inc. (NXGL) director Robert Henry Scott reportó ventas en el mercado abierto bajo un plan Rule 10b5-1. La fecha de la transacción más temprana es 10/02/2025. Vendió 825 acciones el 10/02/2025 a $2.50 por acción y 7,175 acciones el 10/03/2025 a un precio medio ponderado de $2.5502, reduciendo sus participaciones directas de 120,531 a 113,356 acciones. La presentación indica que las acciones fueron originalmente compradas en el mercado abierto el 03/01/2024.

NEXGEL, Inc. (NXGL) 이사 Robert Henry Scott은 규칙 10b5-1 계획에 따른 공개시장 매매를 보고했습니다. 가장 이른 거래일은 10/02/2025입니다. 그는 825주를 10/02/2025에 주당 $2.50에, 7,175주를 10/03/2025에 가중평균가 $2.5502로 매각하여 그의 직접 보유 주식이 120,531주에서 113,356주로 감소했습니다. 제출서에 따르면 이 주식은 원래 2024/03/01에 공개시장에서 매수된 것으로 명시되어 있습니다.

NEXGEL, Inc. (NXGL) administrateur Robert Henry Scott a signalé des ventes sur le marché libre dans le cadre d'un plan Rule 10b5-1. La date de transaction la plus ancienne est 10/02/2025. Il a vendu 825 actions le 10/02/2025 à $2.50 par action et 7,175 actions le 10/03/2025 à un prix moyen pondéré de $2.5502, réduisant ses participations directes de 120,531 à 113,356 actions. Le dépôt indique que les actions ont été achetées à l'origine sur le marché libre le 03/01/2024.

NEXGEL, Inc. (NXGL) Vorstand Robert Henry Scott meldete Verkäufe am offenen Markt im Rahmen eines Plans nach Rule 10b5-1. Das früheste Transaktionsdatum ist 10/02/2025. Er verkaufte 825 Aktien am 10/02/2025 zu $2.50 pro Aktie und 7,175 Aktien am 10/03/2025 zu einem gewichteten Durchschnittspreis von $2.5502, wodurch seine direkten Beteiligungen von 120,531 auf 113,356 Aktien sinken. Die Einreichung gibt an, dass die Aktien ursprünglich im offenen Markt am 03/01/2024 gekauft wurden.

NEXGEL, Inc. (NXGL) المدير Robert Henry Scott أبلغ عن مبيعات في السوق المفتوحة بموجب خطة Rule 10b5-1. أقرب تاريخ للصفقة هو 10/02/2025. باع 825 سهماً في 10/02/2025 بسعر $2.50 للسهم و 7,175 سهماً في 10/03/2025 عند سعر متوسط وزني قدره $2.5502 للسهم، مما قلّل حصته المباشرة من 120,531 إلى 113,356 سهماً. تقول الوثيقة أن الأسهم قد اشتُريت أصلاً في السوق المفتوحة في 03/01/2024.

NEXGEL, Inc. (NXGL) 董事 Robert Henry Scott 根据 Rule 10b5-1 计划披露了在公开市场的出售。最早的交易日期为 10/02/2025。他在 10/02/2025 以每股 $2.50 的价格出售了 825 股,在 10/03/2025 以加权平均价格 $2.5502 出售了 7,175 股,使他的直接持股从 120,531 股降至 113,356 股。文件显示这些股票最初是在 2024/03/01 在公开市场购买的。

Positive
  • Use of a Rule 10b5-1 trading plan indicates transactions were pre-arranged and not opportunistic
  • Transparent disclosure of sale dates, prices, and original purchase date (03/01/2024)
Negative
  • Reduction in direct ownership from 120,531 to 113,356 shares may marginally decrease insider stake
  • Weighted-average sale price of $2.5502 is lower than many higher historical intraday prices (if any), which could limit proceeds

Insights

Director sold 8,000 NXGL shares under a pre-arranged 10b5-1 plan.

The transactions are recorded as open-market sales executed under a Rule 10b5-1 plan, with 825 shares sold at $2.50 on 10/02/2025 and 7,175 shares sold at a weighted average of $2.5502 on 10/03/2025. Ownership declined from 120,531 to 113,356 shares, showing a modest reduction in direct beneficial ownership.

Such sales under a 10b5-1 plan are typically pre-scheduled to avoid trading on material nonpublic information; the filing also discloses the original purchase date of 03/01/2024. Watch for subsequent Forms 4 that disclose any additional plan-based trades or changes in ownership that could materially affect insider ownership percentages in the near term.

NEXGEL, Inc. (NXGL) direttore Robert Henry Scott ha riferito vendite sul mercato aperto nell'ambito di un piano Rule 10b5-1. La data di transazione più antica è 10/02/2025. Ha venduto 825 azioni il 10/02/2025 a $2.50 per azione e 7,175 azioni il 10/03/2025 a un prezzo medio ponderato di $2.5502, riducendo le sue partecipazioni dirette da 120,531 a 113,356 azioni. La dichiarazione indica che le azioni sono state originariamente acquistate sul mercato aperto il 03/01/2024.

NEXGEL, Inc. (NXGL) director Robert Henry Scott reportó ventas en el mercado abierto bajo un plan Rule 10b5-1. La fecha de la transacción más temprana es 10/02/2025. Vendió 825 acciones el 10/02/2025 a $2.50 por acción y 7,175 acciones el 10/03/2025 a un precio medio ponderado de $2.5502, reduciendo sus participaciones directas de 120,531 a 113,356 acciones. La presentación indica que las acciones fueron originalmente compradas en el mercado abierto el 03/01/2024.

NEXGEL, Inc. (NXGL) 이사 Robert Henry Scott은 규칙 10b5-1 계획에 따른 공개시장 매매를 보고했습니다. 가장 이른 거래일은 10/02/2025입니다. 그는 825주를 10/02/2025에 주당 $2.50에, 7,175주를 10/03/2025에 가중평균가 $2.5502로 매각하여 그의 직접 보유 주식이 120,531주에서 113,356주로 감소했습니다. 제출서에 따르면 이 주식은 원래 2024/03/01에 공개시장에서 매수된 것으로 명시되어 있습니다.

NEXGEL, Inc. (NXGL) administrateur Robert Henry Scott a signalé des ventes sur le marché libre dans le cadre d'un plan Rule 10b5-1. La date de transaction la plus ancienne est 10/02/2025. Il a vendu 825 actions le 10/02/2025 à $2.50 par action et 7,175 actions le 10/03/2025 à un prix moyen pondéré de $2.5502, réduisant ses participations directes de 120,531 à 113,356 actions. Le dépôt indique que les actions ont été achetées à l'origine sur le marché libre le 03/01/2024.

NEXGEL, Inc. (NXGL) Vorstand Robert Henry Scott meldete Verkäufe am offenen Markt im Rahmen eines Plans nach Rule 10b5-1. Das früheste Transaktionsdatum ist 10/02/2025. Er verkaufte 825 Aktien am 10/02/2025 zu $2.50 pro Aktie und 7,175 Aktien am 10/03/2025 zu einem gewichteten Durchschnittspreis von $2.5502, wodurch seine direkten Beteiligungen von 120,531 auf 113,356 Aktien sinken. Die Einreichung gibt an, dass die Aktien ursprünglich im offenen Markt am 03/01/2024 gekauft wurden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Henry Scott Robert

(Last) (First) (Middle)
C/O NEXGEL, INC.
2150 CABOT BLVD, WEST, SUITE B

(Street)
LANGHORNE PA 19047

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEXGEL, INC. [ NXGL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/02/2025 S 825(1) D $2.5(2) 120,531 D
Common Stock 10/03/2025 S 7,175(1) D $2.5502(3) 113,356 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The Reporting Person sold these shares pursuant to a Rule 10b5-1 trading plan. The shares were originally purchased by the Reporting Person in the open market on March 1, 2024.
2. The Reporting Person sold all 825 shares of common stock in the open market at a price of $2.5000 per share.
3. Represents the weighted average of open market sale transactions ranging from $2.5350 to $2.5700 per share. The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price sold if requested by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
/s/ Scott Robert Henry 10/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NXGL director Robert Henry Scott sell?

He sold a total of 8,000 shares: 825 on 10/02/2025 at $2.50 and 7,175 on 10/03/2025 at a weighted average of $2.5502.

Were the NXGL sales part of a 10b5-1 plan?

Yes. The filing states the shares were sold pursuant to a Rule 10b5-1 trading plan.

How did the sales change the director's ownership in NXGL?

Direct beneficial ownership declined from 120,531 shares to 113,356 shares after these transactions.

When were the sold shares originally purchased?

The filing discloses the shares were originally purchased in the open market on 03/01/2024.

Does the Form 4 indicate any derivatives or option exercises?

No. Table II (derivative securities) shows no reported transactions; only open-market common stock sales are disclosed.
Nexgel Inc

NASDAQ:NXGL

NXGL Rankings

NXGL Latest News

NXGL Latest SEC Filings

NXGL Stock Data

20.49M
6.82M
15.54%
8.94%
0.46%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LANGHORNE